This mixed-methods study follows a prospective cohort of patients receiving Mifeprex ®
(mifepristone) for medication abortion dispensed by pharmacists after undergoing standard
clinical evaluation. Women participating in this study will obtain mifepristone and
misoprostol from the pharmacy instead of in the clinic. To assess feasibility, acceptability,
and effectiveness of pharmacy dispensing of mifepristone, the study will survey patients,
evaluate their clinical outcomes from electronic health records, and survey and interview
pharmacists at study sites.
Phase:
Phase 4
Details
Lead Sponsor:
Daniel Grossman University of California, San Francisco
Collaborators:
Kaiser Permanente Planned Parenthood of the Great Northwest and the Hawaiian Islands University of California, Davis University of California, San Diego University of Washington